Clinical trial · Observational
Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients
Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients: A Prospective Study
NCT02317757CI-TRIAL-00021620unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
These days, there is higher proportion of elderly cancer patients. Most of them have comorbidities, borderline performance status and nutritional status. The discontinuation of chemotherapy due to unbearable toxicities was not uncommon. Comprehensive geriatric assessment might be beneficial in selection of suitable elderly patients for chemotherapy administration.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- cancer patients receiving chemotherapy
- description
- Patients who are older than 70 years old receiving chemotherapy
Primary outcomes (1)
- measure
- predisposing factors of patients developed grade 3 or 4 chemotherapy toxicity
- timeFrame
- from starting chemotherapy to 1 month after last dose of chemotherapy
Secondary outcomes (2)
- measure
- incidence of grade 3 or 4 chemotherapy toxicity in elderly
- timeFrame
- from starting chemotherapy to 1 month after last dose of chemotherapy
- measure
- Factors associated with good quality of life during receiving chemotherapy
- timeFrame
- from starting chemotherapy to 1 month after last dose of chemotherapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * more than 70 years of age * plan to receive first cycle of chemotherapy * histologically or cytologically proved of cancer Exclusion Criteria: * patients who have concurrent chemoradiotherapy * patients who received local chemotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.